Boiron Faces New False Ad Suit Over Homeopathic Flu Drug
By Linda Chiem (September 11, 2013, 5:12 PM EDT) -- A plaintiff who opted out of a proposed $12 million false advertising class settlement with homeopathic medicine maker Boiron Inc. launched a separate suit Monday in California state court alleging the company deceptively advertised its Oscillococcinum homeopathic remedy as capable of relieving flu-like symptoms.
Plaintiff Leonidas Jovel alleges Boiron's false misrepresentations of the health benefits of Oscillo deceived consumers into paying a premium for Oscillo — which can cost between $12 and $20 a box and is available in six, 12 or 30 dosages — knowing that the product's active ingredient, Anas Barbariae, is diluted and doesn't relieve flu-like symptoms as...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!